Related Experiment Video
Updated: Aug 12, 2026
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Update on tumor vaccines
1Molecular Immunology Group, Southampton University Hospitals, UK.
Abstract:
Vaccination against tumor has always been an attractive idea for the treatment of patients bearing tumor. By harnessing the host's own immune response the attack on tumor cells would act on a continuing basis, with emerging tumor cells stimulating their own destruction. However, the approach has been hampered by our poor understanding of the nature of tumor antigens and of the pathways by which immune cells might operate against tumor growth. Recent developments in molecular biology and immunology are remedying this deficiency and bringing vaccination to the forefront of new approaches to treatment of a range of tumors. Results obtained in B-cell tumors, where the idiotypic immunoglobulin at the cell surface provides a well-defined tumor antigen, are already indicating exciting possibilities as well as delineating problems. There is considerable clinical evidence that patients have some intrinsic ability to control tumor growth and that certain tumors remain dormant for long periods. Attempts to understand and perhaps stimulate the mechanisms involved are being made through the use of biological modifiers and by manipulating potential effector cells in vitro. Ideally this approach, which may include non-specific and specific elements, could be combined with specific vaccination in order to combat the apparent ability of many tumor cells to evade host defences.
Insights
Cancer vaccination harnesses the immune system to fight tumors. Advances in immunology and molecular biology are making tumor vaccination a promising treatment strategy, especially for B-cell tumors.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Cancer vaccination is a long-standing therapeutic goal, aiming to utilize the host's immune system for sustained tumor cell destruction.
- Past limitations included poor understanding of tumor antigens and immune cell mechanisms against cancer growth.
Purpose of the Study:
- To review recent advancements in molecular biology and immunology that are advancing cancer vaccination strategies.
- To highlight the potential of cancer vaccination as a forefront treatment approach for various tumors.
- To discuss findings from B-cell tumor vaccination studies, focusing on idiotype as a tumor antigen.
Main Methods:
- Review of recent developments in molecular biology and immunology relevant to cancer vaccination.
- Analysis of clinical evidence regarding the host's intrinsic ability to control tumor growth.
- Exploration of strategies involving biological modifiers and in vitro manipulation of effector cells.
Main Results:
- Developments in molecular biology and immunology are improving our understanding of tumor antigens and immune pathways.
- Studies in B-cell tumors using idiotype as a specific tumor antigen show promising results and identify challenges.
- Clinical evidence suggests the host possesses mechanisms to control tumor growth, with some tumors remaining dormant.
Conclusions:
- Cancer vaccination is emerging as a key strategy for treating diverse tumors, driven by scientific progress.
- Understanding tumor antigens and immune mechanisms is crucial for effective vaccination.
- Combining specific vaccination with non-specific immune stimulation may overcome tumor evasion tactics.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...